Pemafibrate and telmisartan combo may reverse fatty liver

Drug Target Review·Oct 7

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A combination of pemafibrate and telmisartan may reverse fatty liver disease. The potential treatment, which combines two commonly prescribed heart drugs, has shown promise in animal studies. The findings suggest that this combination could not only reverse fatty liver disease but also reduce cardiovascular risk.

Full coverage

Two common drugs may reverse fatty liver disease, study finds

ScienceDaily·Apr 22

Combining These Two Commonly Prescribed Drugs May Reverse Fatty Liver, Reveals Study

NDTV·Apr 23

Fatty liver: 2 heart drugs reverse disease in animal study

Medical News Today·Oct 16

Two Widely Used Heart Drugs Show Promise For Reversing Early Fatty Liver Disease And Cutting Cardiovascular Risk In Animal Studies

Medical Daily·Apr 23

Two common drugs could reverse fatty liver disease

ScienceDaily·Oct 12

Two common heart medicines may reverse fatty liver disease and cut heart risks, study suggests

Moneycontrol.com·Oct 13

Deadly fatty liver could be reversed with this surprising two-drug heart combo, as per doctors

The Economic Times·Oct 14

Existing Drugs Combine To Fight World’s Most Common Liver Disease

SciTechDaily·Oct 6

View original report at Drug Target Review ↗

Fetching the latest headlines…